These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 20678586
1. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate. Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Kurata T, Sata T, Kojima A. Vaccine; 2010 Sep 14; 28(40):6588-96. PubMed ID: 20678586 [Abstract] [Full Text] [Related]
3. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ. J Infect Dis; 2007 Jun 01; 195(11):1607-17. PubMed ID: 17471430 [Abstract] [Full Text] [Related]
5. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V. Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):230-9. PubMed ID: 18372050 [Abstract] [Full Text] [Related]
6. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development. Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J. Expert Rev Vaccines; 2007 Apr 15; 6(2):183-91. PubMed ID: 17408368 [Abstract] [Full Text] [Related]
7. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Garg H, Sedano M, Plata G, Punke EB, Joshi A. J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28794019 [Abstract] [Full Text] [Related]
9. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease. Alonso-Padilla J, de Oya NJ, Blázquez AB, Escribano-Romero E, Escribano JM, Saiz JC. Vaccine; 2011 Feb 17; 29(9):1830-5. PubMed ID: 21211580 [Abstract] [Full Text] [Related]
10. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H, Paul AM, Sun H, He J, Yang M, Bai F, Chen Q. Vaccine; 2018 Mar 27; 36(14):1846-1852. PubMed ID: 29490880 [Abstract] [Full Text] [Related]
13. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. Holmes DA, Purdy DE, Chao DY, Noga AJ, Chang GJ. J Clin Microbiol; 2005 Jul 27; 43(7):3227-36. PubMed ID: 16000440 [Abstract] [Full Text] [Related]
15. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Bonafé N, Rininger JA, Chubet RG, Foellmer HG, Fader S, Anderson JF, Bushmich SL, Anthony K, Ledizet M, Fikrig E, Koski RA, Kaplan P. Vaccine; 2009 Jan 07; 27(2):213-22. PubMed ID: 18996430 [Abstract] [Full Text] [Related]
16. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines. Hughes HR, Crill WD, Davis BS, Chang GJ. Virology; 2012 Mar 15; 424(2):129-37. PubMed ID: 22244913 [Abstract] [Full Text] [Related]